{
  "conversation_id": "a6579bfa0acc3910cbb8a256d0a4a890cbd851c667b599271f8c87cd453a9f0c",
  "chat_history": "{\n  \"messages\": [\n    {\n      \"metadata\": {},\n      \"content_type\": \"message\",\n      \"role\": \"user\",\n      \"items\": [\n        {\n          \"metadata\": {},\n          \"content_type\": \"text\",\n          \"text\": \"Given the presence of a KRAS p.G12C mutation, what are the potential benefits and risks of transitioning to KRAS-directed treatment with adagrasib? How might this change the patient's prognosis?\"\n        }\n      ]\n    },\n    {\n      \"ai_model_id\": \"gpt-5-mini\",\n      \"metadata\": {\n        \"logprobs\": null,\n        \"id\": \"chatcmpl-CBcvKexHA7TsP3EZEOxC25mgQSgOt\",\n        \"created\": 1756887266,\n        \"system_fingerprint\": null,\n        \"usage\": {\n          \"prompt_tokens\": 1256,\n          \"completion_tokens\": 1813\n        }\n      },\n      \"content_type\": \"message\",\n      \"role\": \"assistant\",\n      \"name\": \"Orchestrator\",\n      \"items\": [\n        {\n          \"metadata\": {},\n          \"content_type\": \"text\",\n          \"text\": \"Planned moderation checklist\\n- Collect the required patient identifier and any missing clinical details.\\n- Retrieve the patient timeline and build a concise clinical summary.\\n- Derive current patient status (staging, performance, prior treatments).\\n- Ask guideline- and research-focused agents to provide an evidence-based overview of benefits, risks, and prognosis implications for adagrasib.\\n- Return a short, consolidated summary and ask whether to proceed to trial matching / report generation.\\n\\nPlanned sequence and roles (what will happen next)\\n1) PatientHistory \u2014 will fetch the patient timeline and history. I need a patient ID string from you to proceed.  \\n2) PatientStatus \u2014 will use the history to produce current status (age, stage, primary site, histology, biomarkers, prior treatments, ECOG).  \\n3) ClinicalGuidelines \u2014 will provide an evidence-based discussion of potential benefits and risks of KRAS G12C\u2013directed therapy with adagrasib and how it might affect prognosis (note: ClinicalGuidelines can discuss general guidance and evidence; I will not give direct treatment recommendations).  \\n4) MedicalResearch \u2014 will supply trial results and literature supporting the benefit/risk statements (e.g., KRYSTAL-1 results).  \\n5) ClinicalTrials (optional) \u2014 if you want, this agent can look for relevant active trials given the patient\u2019s status.  \\n6) Radiology / ReportCreation (optional) \u2014 included only if you want imaging review or a tumor-board style document.\\n\\nSpecial rule (applies to all agents)\\n- Each agent, after completing their task, must yield the chat back to me (the Orchestrator) and conclude their reply with: \\\"back to you: Orchestrator\\\".\\n\\nWhat I need from you now (User)\\n- User, please provide the patient ID as a string (required). If you do not have a patient ID, say so and indicate whether you want a general, non\u2013patient-specific overview.  \\n- If you want a personalized response but cannot provide a patient ID, please supply these key details instead: diagnosis (cancer type), stage, age, histology, prior treatments, ECOG performance status, and whether KRAS p.G12C is the only actionable mutation.\\n\\nPatientHistory, please confirm what you require to proceed (e.g., exact patient ID string and any preferred date range or notes) and whether you need any additional inputs. Conclude with: \\\"back to you: Orchestrator\\\".\\n\\nUser, please confirm you want me to proceed with that plan and provide the patient ID (or say you prefer a general overview).\"\n        }\n      ],\n      \"finish_reason\": \"stop\"\n    }\n  ]\n}",
  "patient_id": null,
  "patient_data": [],
  "display_blob_urls": [],
  "display_clinical_trials": [],
  "output_data": [],
  "healthcare_agents": {}
}